Correlation Between Continuous Glucose Monitoring and Intermittent Glucose Monitoring Values and Pregnancy Outcomes

This study is ongoing, but not recruiting participants.

Sponsors and Collaborators:	Stanford University Santa Clara Valley Health & Hospital System
Information provided by:	Stanford University
ClinicalTrials.gov Identifier:	NCT00186004

Purpose

We wish to find out if in non-diabetic pregnancies, as well as diabetic pregnancies, additional data obtained by Continuous Glucose Monitoring improves perinatal risk prediction.

Condition	Intervention
Insulin Resistance	Device: Continuous Glucose Monitor

Drug Information available for: Dextrose

U.S. FDA Resources

Study Type:	Observational
Study Design:	Prospective
Official Title:	Correlation Between Continuous Glucose Monitoring and Intermittent Glucose Monitoring Values and Pregnancy Outcomes

Further study details as provided by Stanford University:

Estimated Enrollment:

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Female
Accepts Healthy Volunteers:	Yes

Criteria

Inclusion Criteria::- Pregnant patients under 28 weeks gestation
 Exclusion Criteria:- Pre-gestational diabetes

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00186004

Locations

United States, California
Stanford University School of Medicine
Stanford, California, United States, 94305

Sponsors and Collaborators

Stanford University

Santa Clara Valley Health & Hospital System

Investigators

Principal Investigator:

Yasser Yehia El-Sayed

Stanford University

More Information

Journal of Diabetes Science and Technology. 2008 May;2(3):456-460 This link exits the ClinicalTrials.gov site

Study ID Numbers:	78694
Study First Received:	September 13, 2005
Last Updated:	November 19, 2008
ClinicalTrials.gov Identifier:	NCT00186004
Health Authority:	United States: Institutional Review Board

Study placed in the following topic categories:

Hyperinsulinism
Metabolic Diseases
Insulin Resistance
Metabolic disorder
Glucose Metabolism Disorders

ClinicalTrials.gov processed this record on January 15, 2009